Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study

Title
Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study
Authors
Keywords
-
Journal
JOURNAL OF HEPATOLOGY
Volume 61, Issue 4, Pages 761-769
Publisher
Elsevier BV
Online
2014-06-02
DOI
10.1016/j.jhep.2014.05.030

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started